Product ID |
Product Name |
CAS# |
Purity |
Y3285852 |
Enpatoran |
2101938-42-3 |
99% |
Y1256142 |
Orexin receptor antagonist 2 |
1457940-75-8 |
98% |
Y1260513 |
BMS-986202 |
1771691-34-9 |
99% |
Y3102588 |
SETD2-IN-1 TFA |
2411759-92-5 |
99% |
Y1256093 |
Thalidomide-Piperazine-PEG1-COOH |
2731007-11-5 |
99% |
Y1256163 |
Thalidomide-NH-PEG3-COOH |
2375283-62-6 |
98% |
Y1256094 |
Vercirnon sodium |
886214-18-2 |
98% |
Y3318092 |
FT206 |
2278274-34-1 |
98.03% |
Y1260486 |
KW-8232 |
217813-15-5 |
98% |
Y1260537 |
TRC-766 |
1810734-44-1 |
98% |
Y3111960 |
HCV-IN-31 |
1998705-62-6 |
99% |
Y1260487 |
GnRH antagonist 2 |
1709823-61-9 |
98% |
Y3101521 |
AUTAC4 |
2267315-04-6 |
99% |
Y3316631 |
COG1410 |
878009-24-6 |
98.84% |
Y3286144 |
Golgicide A-2 |
1394285-50-7 |
99% |
Y1263369 |
MRTX9768 |
2629314-68-5 |
99% |
Y3287938 |
MI-1061 TFA |
1410737-35-7 |
95% |
Y3291564 |
(E/Z)-Sivopixant |
1640808-39-4 |
98% |
Y3151690 |
ABT-107 |
855291-54-2 |
98% |
Y1232795 |
hSMG-1 inhibitor 11e |
1402452-10-1 |
99% |
Y1232855 |
Mito-LND |
2361564-49-8 |
97% |
Y1232723 |
ASK1-IN-2 |
2541792-70-3 |
98% |
Y1232781 |
AT-130 |
211364-06-6 |
98% |
Y3312699 |
AT-527 |
2241337-84-6 |
99% |
Y3101552 |
SG3199 |
1595275-71-0 |
98% |
Y3104951 |
a-MSH TFA |
171869-93-5 |
97% (HPLC) |
Y1232856 |
Tuberculosis inhibitor 3 |
2219325-28-5 |
98% |
Y3103873 |
Glucocorticoid receptor agonist-1 |
2166375-82-0 |
99% |
Y1232749 |
USP7-IN-8 |
2009273-60-1 |
98% |
Y1341401 |
Fmoc-aminooxy-PEG2-NH2 |
190249-87-7 |
98% |
Y3103911 |
Aminohexylgeldanamycin |
485395-71-9 |
99% |
Y3103853 |
8-Bromo-6-chloroimidazo[1,5-a]pyridine |
1427400-82-5 |
95% |
Y3306835 |
7-Bromo-1H-indole-5-carboxylicacid |
1360950-90-8 |
95% |
Y3263081 |
Methyl5-amino-6-methylnicotinate |
1399183-37-9 |
95% |
Y1232735 |
1-(6-Bromo-5-methyl-1H-indazol-1-yl)ethanone |
1418736-40-9 |
97% |
Y3307221 |
4-(3-(2H-1,2,3-TRIAZO-2-YL)PHENYLAMINO)-2-((1R,2S)-2-AMINOCYCLOHEXYLAMINO) PYRIMIDINE-5-CARBOXAMIDE ACETATE |
1370261-98-5 |
99% |
Y3105173 |
3-(Trifluoromethyl)tetrahydro-2H-pyran-3-ol |
1341352-20-2 |
95% |
Y3105197 |
5-Iodo-4-methyl-7H-pyrrolo[2,3-d]pyrimidine |
1303426-83-6 |
95% |
Y3105213 |
3-(Aminomethyl)tetrahydro-2H-pyran-3-ol |
1342771-66-7 |
95% |
Y3105191 |
3-Chloro-2-(trifluoromethoxy)benzoicacid |
1261822-68-7 |
95% |
Y3109978 |
6-Bromo-1-tosyl-1H-indazole-4-carbonitrile |
1245464-56-5 |
97% |
Y3272215 |
5-Methyl-2-(trifluoromethoxy)benzoicacid |
1261573-49-2 |
95% |
Y3262089 |
2-chloro-4-methylquinoline-7-carboxylic acid |
124307-93-3 |
95% |
Y3318327 |
Methyl 2-amino-5-iodothiazole-4-carboxylate |
1235034-76-0 |
95% |
Y3270547 |
2-Chloro-5-methyloxazole-4-carboxylicacid |
1240600-64-9 |
95% |
Y1321480 |
Iridium, bis[2,4-dimethyl-6-(4-methyl-2-quinolinyl-¬-N)phenyl-¬-C](2,2,6,6-tetramethyl-3,5-heptanedionato-¬-O3,¬-O5) |
1228537-80-1 |
95% |
Y3313694 |
(6-Bromo-5-fluoro-pyridin-3-yl)-acetic acid |
1227593-08-9 |
98% |
Y3309609 |
4-Chloro-1H-indol-7-ol |
1227496-90-3 |
95% |
Y3316257 |
1-(2,3-dichloropyridin-4-yl)ethanone |
1196157-52-4 |
96% |
Y3208684 |
2-(tert-Butoxycarbonyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepine-7-carboxylicacid |
1158744-01-4 |
95% |
Y3197462 |
(S)-methyl 2-amino-3-(pyridin-3-yl)propanoate |
112455-83-1 |
95% |
Y3109257 |
3-Methyl-1H-indol-7-ol |
1125-35-5 |
98% |
Y3109499 |
methyl 3-(4-(methylthio)phenyl)-3-oxopropanoate |
108818-59-3 |
97% |
Y3199640 |
tert-Butyl((1S,2S)-2-(aminomethyl)cyclopentyl)carbamate |
1030391-03-7 |
95% |
Y3195537 |
2-(1-Methylcyclopropyl)acetaldehyde |
102861-46-1 |
93% |
Y1232713 |
1-(4-methoxybenzyl)isoquinoline |
10172-49-3 |
98% |
Y1237097 |
7-methylquinoline-5-carboxylic acid |
1016257-78-5 |
98% |
Y3209565 |
(3-Bromo-5-(trifluoromethyl)phenyl)hydrazine hydrochloride |
1001395-26-1 |
95% |
Y1326980 |
(3R,4R)-4-Aminopiperidin-3-ol |
1007596-94-2 |
95% |
Y3265278 |
2-(3,5-Difluoropyridin-2-yl)aceticacid |
1000518-01-3 |
95% |
Y3269155 |
Cyclohexanol, 4-amino-2,2-dimethyl-, hydrochloride (1:1) |
2253632-25-4 |
80% |
Y1232784 |
4-bromo-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one |
1936135-61-3 |
95% |
Y3310642 |
2-[(4-chlorophenyl)sulfanyl]-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]acetamide |
895470-67-4 |
99% |
Y3267635 |
Furo[3,4-b]pyrazine-1(2H)-carboxylic acid, hexahydro-, 1,1-dimethylethyl ester, (4aR,7aS)-rel- |
1314393-75-3 |
95% |
Y3316347 |
Isogambogenic Acid |
887923-47-9 |
95% |
Y3292201 |
Levocetirizine Amide |
909779-33-5 |
95% |
Y3314253 |
Chamaejasmenin D |
865852-47-7 |
95% |
Y3265503 |
3-(2-methoxyethyl)-2-sulfanylidene-1H,2H,3H,4H-pyrido[2,3-d]pyrimidin-4-one |
688793-17-1 |
98% |
Y1237042 |
(4Z)-4-[(furan-2-yl)methylidene]-2-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-5-one |
16352-80-0 |
95% |
Y3315160 |
N-Fmoc-N-Methyl-(S)-2-amino-4,4-dimethylpentanoic acid |
1357308-53-2 |
97%,ee98% |
Y3109629 |
(4R)-1-Fmoc-4-ethoxy-L-proline |
1446478-31-4 |
97% |
Y3314140 |
11-(Methylamino)undecanoic acid |
7408-80-2 |
97% |
Y3109648 |
4-Ethyl-L-norleucine |
134055-71-3 |
97% |
Y3286147 |
N-Fmoc-4-chloro-3-fluoro-D-phenylalanine |
2002503-14-0 |
97% |
Y3110488 |
4-Chloro-3-fluoro-L-phenylalanine |
1269791-95-8 |
95% |
Y1302983 |
(S)-2-(Fmoc-amino)-5-cyclopentylpentanoic acid |
2349606-67-1 |
95% |
Y1322306 |
2-Chloro-4-fluoro-D-phenylalanine |
1212966-63-6 |
95% |
Y3151516 |
N-Boc-4-chloro-3-fluoro-D-phenylalanine |
1001123-84-7 |
97% |
Y1344478 |
(S)-2-(N-Fmoc-N-methyl-amino)-5-methylhexanoic acid |
2260800-15-3 |
98% |
Y3314491 |
(S)-2-(N-Fmoc-N-methylamino)-7-octenoic acid |
1808268-11-2 |
97% |
Y1343925 |
2'-Methoxy-biphenyl-2-methanol |
63506-57-0 |
97% |
Y3305678 |
N-Methyl-D-tryptophan |
862504-05-0 |
98% |
Y1336326 |
2-Bromo-4-(1,1-dimethylethyl)-1-nitrobenzene |
860687-69-0 |
98% |
Y3112992 |
2-chloro-5-(2-methylpiperidine-1-carbonyl)pyridine |
385408-28-6 |
98% |
Y3111986 |
1-(2-fluorophenyl)-4-[4-(pyrrolidine-1-sulfonyl)benzoyl]piperazine |
609792-38-3 |
98% |
Y3111992 |
1-phenylcyclopropane-1-carbohydrazide |
851764-93-7 |
95% |
Y3311036 |
Bis(2,4-difluorobenzyl)amine |
1284487-51-9 |
99% |
Y3106363 |
5,6-Dihydro-4H-cyclopenta[d]thiazole-4-carboxylic acid |
1356920-29-0 |
95% |
Y3295700 |
PF-06685249 |
1467059-70-6 |
98% |
Y3106530 |
Methyl 3-carbamoyl-5-chlorobenzoate |
917388-36-4 |
95% |
Y3106410 |
2,3-Difluoro-4-methoxybenzeneboronic acid pinacol ester |
1809298-92-7 |
95% |
Y3111977 |
5-Cyanomethyl-2-fluorobenzeneboronic acid pinacol ester |
1637543-22-6 |
95% |
Y1337322 |
(3-Hydroxymethyl-piperidin-1-yl)-acetic acid |
1156112-79-6 |
97% |
Y3288608 |
Oseltamivir-d3 EP impurity C |
1242184-43-5 |
98% |
Y1240483 |
ELOVL6-IN-1 |
1185736-98-4 |
99% |
Y1236080 |
(Rac)-PT2399 |
1672662-07-5 |
99% |
Y3288219 |
PQCA |
1144504-35-7 |
99% |
Y1236073 |
Ziresovir |
1422500-60-4 |
98% |
Y3288217 |
Contezolid |
1112968-42-9 |
99% |
Y3288209 |
GLUT4 activator 1 |
2253733-37-6 |
99% |